Access Scientific's POWERWAND Midline IV Catheter Sets New Industry Standard for Power Injectabilty
October 28, 2015 15:09 ET
|
Access Scientific
SAN DIEGO, Oct. 28, 2015 (GLOBE NEWSWIRE) -- Access Scientific, LLC today announced validation of the POWERWAND® midline IV catheter for power-injectable capability up to 8ml/sec, 325 psi for up...
Proteon Therapeutics Announces Positive Long-Term Results From Phase 2 Study of Investigational New Drug Vonapanitase in Chronic Kidney Disease Patients Undergoing Surgical Creation of an Arteriovenous Fistula for Hemodialysis
March 26, 2015 19:00 ET
|
Proteon Therapeutics, Inc.
DALLAS and WALTHAM, Mass., March 26, 2015 (GLOBE NEWSWIRE) -- Proteon Therapeutics Inc. (Nasdaq:PRTO), a company developing novel, first-in-class therapeutics to address the medical needs of...
Association for Vascular Access (AVA) Works with TV Worldwide to Launch the 'AVA TV' Internet TV Channel
August 13, 2014 11:08 ET
|
TVWorldwide.com
Washington, D.C., Aug. 13, 2014 (GLOBE NEWSWIRE) --
TV Worldwide, since 1999, a pioneering web-based global TV network,
announced that it had teamed with the Association for Vascular
Access (AVA)...